Ethnotherapeutics and modern drug development: The potential of Ayurveda

Current Science

Volumn 73, Issue 11, 1997, Pages 909-928

  Dev, Sukh ^a  

^a UNIVERSITY OF DELHI   (India)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0001428639     PISSN: 00113891     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (279)

1. Sukh Dev, Proc. Indian Natl. Sci. Acad., 1988, 54A, 12. Modern drug may be defined as a clinically efficaceous chemical entity or mixture, of synthetic or natural origin, administered as such or admixed with other entities or vehicles and being produced in a reproducible form under good analytical control. The term clinically efficacious is meant to convey that the said product has undergone pharmacological, toxicological and clinical screening as per accepted parameters of modern medical sciences.
2. See e.g., Konig, H., Angew. Chem. Int. Ed. Engl., 1980, 19, 749.
3. Hileman, B., C&EN, 1996, Jan. 22, 9.
4. For a recent article on the subject with special reference to India, see: Ramalingaswami, V., Curr. Sci., 1996, 70, 1050.
5. See e.g., Wolff, M. E. (ed.). Burger's Medicinal Chemistry and Drug Discovery, Wiley-interscience, New York, 1995, vol. 2;
6. Wermuth C. G. (ed.), Medicinal Chemistry for the 21st Century, Blackwell Scientific, Oxford, 1992, pp. 3-60;
7. Maxwell, R. A. and Eckhardt, S. B., Drug Discovery: A Casebook and Analysis, Humana Press, Clifton, 1990.
8. Gerhartz, W., Yamamoto, Y. S., Campbell, F. T., Pfefferkorn, R. and Rounsaville, J. F. (eds), Ultmann's Encyclopedia of Industrial Chemistry, 1985, A2, 467.
9. Kroschwitz, J. I. and Howe-Grant, M. (eds). Kirk-Othmer Encyclopedia of Chemical Technology, 1992, 2, 893.
10. Nisbet, L. J. and Westley, J. W., Annu. Rep. Med. Chem., 1936, 21, 149.
11. Dower, W. J. and Fodor, S. P. A., Annu. Rep. Med. Chem., 1991, 26, 271.
12. Moos, W. H., Green, G. D. and Pavia, M. R., Annu. Rep. Med. Chem., 1993, 28, 315.
13. Nielsen, J., Chem. Ind., 1994, 902.
14. Desai, M. C., Zuckermann, R. N. and Moos, W. H., Drug Dev. Res., 1994, 33, 174.
15. Furka, A., Drug Dev. Res., 1995, 36, 1.
16. Terrett, N. K., Gardner, M., Gordon, D. W., Kobylecki, R. J. and Steele, J., Tetrahedron, 1995, 51, 8135.
17. Thompson, L. A. and Ellman, J. A., Chem. Rev., 1996, 96, 555.
18. Also see: Chem. Rev., 1997, 97, Febuary issue, entirely devoted to combinatorial chemistry.
19. Borman, S., C&EN, 1996, Feb. 12, 29.
20. Chaiken, I. M. and Janda, K. D. (eds), Molecular Diversity and Combinatorial Chemistry: Libraries and Drug Discovery, American Chemical Society, Washington, DC, 1996.
21. Gracheck, S, J., Miller, P. F. and Marks, J. S., Annu. Rep. Med. Chem., 1993, 28, 161.
22. Green, M. J. and Lutsky, B. N., Annu. Rep. Med. Chem., 1976, 11, 149.
23. Grayson, M. and Eckroth, D. (eds), Kirk-Othmer Encyclopedia of Chemical Technology, 1980, 12, 575;
24. Grayson, M. and Eckroth, D. Kirk-Othmer Encyclopedia of Chemical Technology, 1982, 21, 668.
25. Schaaf, T. K., Annu. Rep. Med. Chem., 1976, 11, 80.
26. Nicolaou, K. C., Gasic, G. P. and Barnette, W. E., Angew. Chem. Int. Ed. Engl., 1978, 17, 293.
27. Anon., Chemtech, 1988, 18, 84.
28. Janssen, P. A. J. and Tollenaere, J. P., in Medicinal Chemistry for the 21st Century (ed. Wermuth, C. G.), Blackwell Scientific, Oxford, 1992, p. 13.
29. Musser, J. H., in Medicinal Chemistry for the 21st Century (ed. Wermuth, C. G.), Blackwell Scientific, Oxford, 1992, p. 25.
30. Blohm, D., Bollschweiler, C. and Hillen, H., Angew. Chem. Int. Ed. Engl., 1988, 27, 207.
31. Venuti, M. C., Annu. Rep. Med. Chem., 1990, 25, 289.
32. Thayer, A. N., C&EN, 1991, Feb. 25, 27.
33. Freidinger, R. M., in Medicinal Chemistry for the 21st Century (ed. Wermuth, C. G.), Blackwell Scientific, Oxford, 1992, p. 233.
34. However see, Taylor, M. D. and Amidon, G. (eds), Peptide-Based Drug Design: Controlling Transport and Metabolism, American Chemical Society, Washington, 1995.
35. Thayer, A. M., C&EN, 1995, June 5, 17.
36. Hirshmann, R., Angew. Chem. Int. Ed., 1991, 30, 1278.
37. Williams, M. and Enna, N, J,. Annu. Rep. Med. Chem., 1986, 21, 211.
38. Black, J. W., Angew, Chem. Int. Ed. Engl., 1989, 28, 886.
39. Walpole, C. S. J. and Wrigglesworth, R., Nat. Prod. Rep., 1989, 311.
40. Erickson, J. W. and Fesik, S. W., Annu. Rep. Med. Chem., 1992, 27, 271.
41. Ganellin, C. R., in Medicinal Chemistry for the 21st Century (ed. Wermuth, C. G.), Blackwell Scientific, Oxford, 1992, p. 3.
42. Schwartz, J. C., in Medicinal Chemistry for the 21st Century (ed. Wermuth, C. G.), Blackwell Scientific, Oxford, 1992, p. 63.
43. Musser, J. H., Annu. Rep. Med. Chem., 1992, 27, 301.
44. Krieger, J. H., C&EN, 1996, April 22, 10;
45. Reynolds, C. H., Holloway, M. K. and Cox, H. R. (eds), Computer-Aided Molecular Design: Applications in Agrochemicals, Materials and Pharmaceuticals, American Chemical Society, Washington, DC, 1995.
46. Mansuri, M. M. and Hitchcock, M. J. M., Chemtech, 1992, 22, 564.
47. Montgomery, J. A. and Shri Niwas, Chemtech, 1993, 23, 30.
48. Johnson, R. K. and Hertzberg, R. P., Annu. Rep. Med. Chem., 1990, 25, 129.
49. Rawls, R., C&EN, 1996, April 8, 37.
50. Hansch, C. and Leo, A., Exploring QSAR: Fundamentals and Applications in Chemistry and Biology, vol. 1;
51. Leo, A., Hansch, C. and Hoekman, D., Exploring QSAR: Hydrophobic, Electronic and Steric Constants, vol. 2, American Chemical Society, Washington, 1995.
52. Maxwell, R. A. and Eckhardt, S. B., Drug Discovery: A Casebook and Analysis, Humana Press, Clifton, 1990.
53. Hannan, P. J., Roy, R., Christman, J. F., Chemtech, 1988, 18, 80.
54. Foye, W. O., in Principles of Medicinal Chemistry (ed. Foye, W. O.), Lea and Febiger, Philadelphia, 1981, p. 697.
55. Sukh Dev, in Plants and Society (eds Swaminathan, M. S. and Kochhar, S. L.), Macmillan, London, 1989, p. 267.
56. Beecher, C. W. W., Farnsworth, N. R. and Gyllenhaal, C., in Natural Products of Woody Plants (ed. Rowe, J. W.), Springer, Berlin, 1989, vol. 2, pp. 1059.
57. Also see: Cragg, G. M., Newman, D. J. and Snader, K. M., J. Nat. Prod., 1997, 60, 52.
58. Mitscher, L. A. and Alshamma, A., Annu. Rep. Med. Chem., 1980, 15, 255.
59. Budavari, S. (ed.), The Merck Index, Merck and Co., Rahway, 1989.
60. This figure has been extrapolated from the data available for the period 1983-91: Annu. Rep. Med. Chem., 1992, 27, 357.
61. Sukh Dev, Proc. Indian Natn. Sci. Acad., 1988, 54A, 12.
62. For further details see: Allen, R. C., Annu. Rep. Med. Chem., 1987, 22, 315;
63. Ong, H. H. and Allen, R. C., Annu. Rep. Med. Chem., 1988, 23, 325.
64. Braquet, P. (ed.), Ginkgolides - Chemistry, Biology, Pharmacology and Clinical Perspectives, J. R. Prous Science, Barcelona, vol. 1, 1988;
65. Braquet, P., Ginkgolides - Chemistry, Biology, Pharmacology and Clinical Perspectives vol. 2, 1989.
66. Both guggulsterones and ginkgolides are currently being marketed as standardized extracts.
67. Data culled from Annu. Rep. Med. Chem., 1992-1996, vols. 27-31.
68. Sankawa, U., in Proceedings of the Seventh Asian Symposium on Medicinal Plants Spices and other Natural Products (eds Cruz, L. J., Concepcion, G. P., Mendigo, M. A. S. and Guevara, B. Q.), University of the Philippines, Manila, 1992, p. 143.
69. Kinghorn, A. D. and Seo, E-K., Chemtech, 1996, 26, 46.
70. See e.g., Farnsworth, N. R. and Bingel, A, S., in New Natural Products and Plant Drugs with Pharmacological, Biological or Therapeutical Activity (eds Wagner, H., Wolff, P.), Springer, Berlin, 1977, p. 1.
71. Hartwell, J. L., Lloydia, 1971, 32, 204;
72. Cordell, G. A., in New Natural Products and Plant Drugs with Pharmacological, Biological or Therapeutical Activity (eds Wagner, H. and Wolff, P.), Springer, Berlin, 1977, p. 54;
73. Aszalos, A. (ed.), Antitumor Compounds of Natural Origin, CRC Press, Boca Raton, 1982.
74. However, it must be pointed out that two compounds (taxol, camptothecin) discovered during these investigations have acquired much importance in rercent years as anti-cancer agents.
75. Aswal, B. S., Bhakuni, D. S., Goel, A. K., Kar, K. and Mehrotra, B. N., Indian J. Exp. Biol., 1984, 22, 487;
76. Rastogi, R. P. and Dhawan, B. N., Indian J. Med. Res., 1982, 76 (suppl.), 27.
77. Desai, H. K. et al., Indian J. Chem., 1973, 11, 1.
78. 44 as 'a chemical whose use in a given indication had little or no precedent before its introduction and whose use also represents a very significant improvement over, or a very significant supplement to, available drugs.'
79. Annu. Rep. Med. Chem., 1995, 30, 376.
80. Sitting, M., Pharmaceutical Manufacturing Encyclopedia, Noyes Data Corporation, Park Ridge, 1979.
81. Woodson, R. E., Yongken, H. W., Schlittler, E. and Schneider, J. A., Rauwolfia: Botany, Pharmacognosy, Chemistry and Pharmacology, Little, Brown and Company, Boston, 1957.
82. Taylor, W. I. and Farnsworth, N. R. (eds), The Catharanthus Alkaloids, Marcel Dekker, New York, 1975.
83. Kraska, A. R., Annu. Rep. Med. Chem., 1979, 14, 132.
84. Loike, J. D., Cancer Chemother. Pharmacol., 1982, 7, 103.
85. Ref. 50, pp. 610, 1440.
86. Gerhartz, W. et al. (eds), Ullmann's Encyclopedia of Industrial Chemistry, VCH Verlag, Weinheim, 1986, vol. A5, p. 21.
87. Suffness, M., Annu. Rep. Med. Chem., 1993, 28, 305.
88. Suffness, M. (ed.). Taxol: Science and Applications, CRC Press, Boca Raton, 1995.
89. Georg, G. I., Chen, T. T., Ojima, I., Vyas, D. M. (eds), Taxane Anticancer Agents: Basic Science and Current Status, American Chemical Society, Washington DC, 1995.
90. Wall, M. E., Wani, M. C., Cook, C. E., Palmer, K. H., McPhail, A. T. and Sim, G. A., J. Am. Chem. Soc., 1966, 88, 3888.
91. Govindachari, T. R. and Viswanathan, N., Plytochemistry, 1972, 11, 3529.
92. Potmesil, M. and Pinedo, H. (eds), Camptothecins: New Anticancer Agents, CRC Press, Boca Raton, 1995.
93. Cheng, X-M., Annu. Rep. Med. Chem., 1995, 30, 301.
94. Pettit, G. R., Pierson, F. H. and Herald, C. L., Anticancer Drugs from Animals, Plants and Microorganisms, John Wiley, New York, 1994.
95. Valeriote, F. A., Corbett, T. H. and Baker, L. H. (eds), Anticancer Drug Discovery and Development: Natural Products as Molecular Models, Kluver Academic, Norwell, 1994.
96. Gueritte-Voegelein, F., Guenard, D., Lavelle, F., LeGoft, M., Mangatal, L. and Potier, P., J. Med. Chem., 1991, 34, 992 and references cited therein.
97. Ref. 41, p. 133.
98. Hertzberg, R. P. and Johnson, R. K., Annu. Rep. Med. Chem., 1993, 28, 167.
99. Compounds which bind to tubulin, interfere with the assembly of microtubules, resulting in mitotic block, while taxol which enhances the rate of microtubules assembly results in the formation of aberrant microtubule bundles, again leading to the arrest of mitosis (Ref. 73, p. 307).
100. Seamon, K. B., Annu. Rep. Med. Chem., 1984, 19, 293.
101. Also see: a. Kupchan, S. M., in Drug Discovery, American Chemical Society, Washington, 1971, p. 1;
102. b. Wagner, H., Hikino, H. and Farnsworth, N. R. (eds), Economic and Medicinal Plant Research, Academic Press, London, 1989, vol. 2;
103. c. Chadwick, D. J. and Marsh, J. (eds), Bioactive Compounds from Plants, John Wiley, Chichester, 1990;
104. Kinghorn, A. D. and Baladrin, M. F. (eds), Human Medicinal Agents from Plants, American Chemical Society, Washington, 1993;
105. e. Gullo, V. P. (ed.), The Discovery of Natural Products with Therapeutic Potential, Butterworth-Heinemann, Boston, 1994.
106. Mukerji, B., Medal Lectures II, Indian National Science Academy, New Delhi, pp. 973.
107. Hartwell, J. L. and Schrecker, A. W., Fortsch. Chem. Org. Naturstoffe, 1958, 15, 83.
108. Spjut, R. W. and Perdue, R. E., Cancer Treatment Rep., 1976, 60, 979.
109. Shibata, S., in Advances in Natural Products Chemistry (eds Natory, S., Ikekawa, N. and Suzuki, M.), Kodansha, Tokyo, 1981, p. 398.
110. Takemi, T., Hasegawa, M., Kumagai, A. and Otsuka, Y. (eds), Herbal Medicine: Kampo, Past and Present, Tsumura Juntendo, Tokyo, 1985.
111. Bai, D., Pure Appl. Chem., 1993, 65, 1103.
112. Xiao, P. G., in Natural Products as Medicinal Agents (eds Beal, J. L. and Reinhard, E.), Hippokrates, Stuttgart, 1981, p. 351.
113. Huang, L., in Natural Products and Drug Research (eds Krogsgaard-Larsen, Christensen, S. B. and Kofod, H.), Munksgaard, Copenhagen, 1984, p. 94.
114. Chang, H. M., Yeung, H. W., Tso, W-W. and Koo, A. (eds), Advances in Chinese Medicinal Materials Research, World Scientific, Singapore, 1985.
115. Sankawa, U., in Proceedings of the Seventh Asian Symposium on Medicinal Plants, Spices and Other Natural Products (eds Cruz, L. J., Concepcion, G. P., Mendigo, M. A. S. and Guevara, B. Q.), University of the Philippines, Manila, 1992, p. 143.
116. Allen, R. C., Annu. Rep. Med. Chem., 1985, 20, 323.
117. Xiao, P. G., in Proceedings of the Seventh Asian Symposium on Medicinal Plants, Spices and other Natural Products (eds Cruz, L. J., Concepcion, G. P., Mendigo, M. A. S. and Guevara, B. Q.), University of the Philippines, Manila, 1992, p. 151.
118. Ong, H. H. and Allen, R. C., Annu. Rep. Med. Chem., 1988, 23, 327.
119. Da-yuan, Z., Abstr. Chinese Med., 1987, 1, 251.
120. Murray, M. C., Annu. Rep. Med. Chem., 1997, 31, 141.
121. Also see: Haynes, R. K. and Vonwiller, S. C., Acc. Chem. Res., 1997, 30, 73.
122. Ref. 100, p. 340.
123. Vlietinck, A., in Biologically Active Natural Products (eds Hostettmann, K. and Lea, P. J.), Clarendon Press, Oxford, 1987, p. 33.
124. Tempesta, M. S. and King, S. R., Annu. Rep. Med Chem., 1994, 29, 325.
125. 'The understanding of a totality of an entity does not arise from a fragmentary knowledge of it' (Charaka Samhita, VI, 4.5).
126. This is now being considered in allopathic medicine! See e.g., Pietroni, P. C., J. R. Soc. Med., 1987, 80, 357.
127. Sharma, S. (ed.), in Realms of Ayurveda, Arnold-Heinemann, New Delhi, 1979, p. 11.
128. For a recent critique see: Chopra, D., Perfect Health, Hormony Books, New York, 1991.
129. See e.g., Dahanukar, S. A. and Thatte, U. M., Ayurveda Revisited, Popular Prakashan, Mumbai, India, 1989, p. 38.
130. Charaka Samhita is, in fact, an edited and enlarged version of an older treatise (Tantra) by Agnivesha, which was based on discussions and proceedings of a series of meetings and symposia, organized by his preceptor Atreya Punarvasu. Charaka Sainhita was redacted and enlarged later by other scholars, most important amongst these, being Drdhabala.
131. Mehta, P. M., in Realms of Ayurveda (ed. Sharma, S.), Arnold-Heinemann, New Delhi, 1979, p. 47.
132. Charaka Samhita (edited and published by Shree Gulab Kunverba Ayurvedic Society), Jamnagar, 1949, vol. I-VI.
133. Sharma, S. P., Charaka Samhita, Chaukhambha Orientalia, Varanasi, 1981, vol. 1-IV.
134. Singhal, G. D., in Realms of Ayurveda (ed. Sharma, S.), Arnold-Heinemann, New Delhi, 1979, p. 124.
135. Majumdar, R. C., in A Concise History of Science in India (eds Bose, D. M., Sen, S. N. and Subbarayappa, B. V.), Indian National Science Academy, New Delhi, 1971, p. 222.
136. Krishnamurthy, K. H., Wealth of Susruta, International Institute of Ayurveda, Coimbatore, 1991.
137. Garde, G. K. (ed.), Sartha Vagbhatta: Ashtangahridaya with Marathi Translation, Aryabhushana Mudranalaya, Pune, 1954.
138. Sarangdhara Samhita (edited and published by Dikshit, Y. G.), Pune, 1908.
139. Pandey, G. (ed.), Bhava Prakash, Chaukhambha Vidya Bhavan, Varanasi, 1960.
140. Namjoshi, A., in Realms of Ayurveda (ed. Sharma, S.), Arnold-Heinemann, New Delhi, 1979, p. 217.
141. Ref. 115, p. 264.
142. See e.g., Ray, P. and Gupta, H. N., Caraka Samhita, National Institute of Sciences of India, New Delhi, 1965, p. 27.
143. Lele, R. D., in Realms of Ayurveda (ed. Sharma, S.), Arnold-Heiemann, New Delhi, 1979, p. 217.
144. Ref. 115, pp. 257-262.
145. Subbarayappa, B. V., in India's Contribution to World Thought and Culture (eds Chandra, L. et al.), Vivekanand Rock Memorial Committee, Madras, 1970, p. 54.
146. Filliozat, J., in India's Contribution to World Thought and Culture (eds Chandra, L. et al.), Vivekanand Rock Memorial Committee, Madras, 1970, p. 67.
147. See Chopra, D., cited in ref. 105.
148. Hartzell, J. F. and Zysk, K. G., J. Alternative Complementary Med., 1995, 1, 297.
149. Sharma, S., Reader's Digest (India), 1978, (November/December), 255.
150. Nitya Anand, in Comprehensive Medicinal Chemistry (eds Hansch, C., Sammes, P. G. and Taylor, J. B.), Pergamon Press, Oxford, (vol. ed. Kennewell, P. D.), 1990, vol. 1, pp. 113-131.
151. Sukh Dev, in Science Teclmology and Industrial Development in India (eds Pakrashi, S. C. and Phondke, G. P.), Publication & Information Directorate, New Delhi, India, 1995, p. 159.
152. Vakil, R. J., Br. Heart J., 1949, 11, 350.
153. See e.g., Sastry, V. V. S., Bull. Indian Inst. History Med., 1976, 6, 102.
154. Gujral, M. L., Sareen, K., Tangri, K. K., Amma, M. K. P. and Roy, A. K., Indian J. Physiol. Pharmacol., 1960, 4, 267.
155. Santhakumari, G., Gujral, M. L. and Sareen, K., Indian J. Physiol. Pharmacol., 1964, 8, 36.
156. Tripathi, S. N., Shastri, V. V. S. and Satyavati, G. V., J. Res. Indian Med., 1968, 2, 10.
157. Mehta, V. L., Malhotra, C. L. and Kalrah, N. S., Indian J. Physiol. Pharmacol., 1968, 12, 87.
158. Khanna, D. S., Agarwal, O. P., Gupta, S. K. and Arora, R. B., Indian J. Med. Res., 1969. 57, 900.
159. Satyavati, G. V., Dwarkanath, C. and Tripathi, S. N., Indian J. Med. Res., 1969, 57, 1950.
160. See e.g., Satyavati, G. V., Indian J. Med. Res., 1988, 87, 327.
161. See e.g., Foye, W. O. (ed.), Principles of Medicinal Chemistry, Lea & Febiger, Philadelphia, 1981, pp. 506.
162. Patil, V. D., Nayak, U. R. and Sukh Dev, Tetrahedron, 1972, 28, 2341.
163. Nityanand, S. and Kapoor, N. K., Indian J. Exp. Biol., 1973, 11, 395.
164. It is remarkable that in Ayurvedic pharmacy practice, raw gugglu is first purified (shodhan) before its incorporation into any formulated remedy. From the purification procedure it is clear that the process rejects the toxic gum portion: see e.g., Garg, D. S., Agarwal, J. P. and Garg, D. D. (eds), Dhanvantri, 1963, 37, 430.
165. Patil, V. D., Nayak, U. R. and Sukh Dev, Tetrahedron, 1973, 29, 341, 1595.
166. Prasad, R. S and Sukh Dev, Tetrahedron, 1976, 32, 1437.
167. Bajaj, A. G. and Sukh Dev, Tetrahedron, 1982, 38, 2949.
168. Kumar, V. and Sukh Dev, Tetrahedron, 1987, 43, 5933.
169. Sukh Dev, in Studies in Natural Products Chemistry (ed. Atta-ur-Rahman), Elsevier, Amsterdam, Netherlands, vol. 5 (Part B), 1989, p. 695.
170. Nityanand, S. and Kapoor, N. K., Indian J. Pharmacol., 1975, 71, 60;
171. Indian J. Biochem. Biophys., 1978, 15, 77.
172. Agarwal, R. C., Singh, S. P., Saran, R. K., Das, S. K., Sinha, N., Asthana, O. P., Gupta, P. P., Nityanand, S., Dhawan, B. N. and Agarwal, S. S., Indian J. Med. Res., 1986, 84, 626.
173. See e.g., Roth, B. D., Sliskovic, D. R. and Trivedi, B. K., Annu. Rep. Med. Chem., 1989, 24, 147.
174. See e.g., various issues of J. Res. Indian Med.,
175. J. Res. Ayur. Sidha,
176. Indian J. Med. Res.,
177. Indian J. Exp. Biol.
178. Satyavati, G. V., Raina, M. K. and Sharma, M. (eds), Medicinal Plants of India, Indian Council of Medical Research, New Delhi, India, vol. 1, 1976.
179. See e.g., Garg, D. S., Agarwal, J. P. and Garg, D. D. (eds), Dhanvantri, 1971, 45, 208.
180. Gaitonde, B. B. and Jetmalani, M. H., Indian J. Pharmacol., 1969, 31, 175;
181. Arch. Int. Pharmacodyn., 1969, 179, 121;
182. Gaitonde, B. B., in Realms of Ayurveda (ed. Sharma, S.), Arnold-Heinemann, New Delhi, India, 1979, p. 248.
183. Sabnis, P. B., Gaitonde, B. B. and Jetmalani, M. H., Indian J. Exp. Biol., 1968, 6, 55;
184. Patel, A. B. and Kanitkar, U. K., Indian Vet. J., 1969, 46, 718.
185. Wagner, H., in Natural Products as Medicinal Agents (eds Beal, J. L. and Reinhard, E.), Hippokrates, Stuttgart, 1981, pp. 217-242.
186. Handa, S. S., Sharma, A. and Chakraborti, K. K., Fitoterapia, 1986, 57, 307.
187. Hikino, H., in Biologically Active Natural Products (eds Hostettmann, K. and Lea, P. J.), Oxford Science Publications, Oxford, UK, 1987, pp. 143-151.
188. Dictionary of Organic Compounds (ed. Buckingham), Chapman and Hall, London, UK, 1989, 5th edn, 7th supplement, p. 88.
189. See e.g., a. Mooss, V. N. S., Ayurvedic Flora Medica, Vaidyasarathy Press Kottayam, India, 1978, p. 54;
190. b, The Wealth of India, Publication and Information Directorate, New Delhi, India, vol. 2B, (Raw materials), 1988, pp. 341.
191. Dictionary of Organic Compounds (ed. Buckingham), Chapman and Hall, London, UK, 1982, vol. 4, 5th edn, pp. 4475.
192. See e.g., Chatterjce, A. and Pakrashi, S. C., The Treatise on Indian Medicinal Plants, Publication and Information Directorate, New Delhi, India, vol. 2, 1992, p. 114.
193. Jois, H. S., Manjunath, B. S. and Venkatarao, S., J. Indian Chem. Soc., 1933, 10, 39.
194. Anderson, T. F. and Voorhees, J. J., Annu. Rev. Pharmacol. Toxicol., 1980, 20, 235.
195. Mehta, G., Nayak, U. R. and Sukh Dev, Tetrahedron, 1973, 29, 1119.
196. Prakasa Rao, A. S. C., Bhalla, V. K., Nayak, U. R. and Sukh Dev, Tetrahedron, 1973, 29, 1127.
197. Damodran, N. P. and Sukh Dev, Tetrahedron, 1973, 29, 1209.
198. Satyavati, G. V., Gupta, A. K. and Tandon, N. (eds), Medicinal Plants of India, Indian Council of Medical Research, New Delhi, India, vol. 2, 1987.
199. Private communication from Dr R. V. Noronha.
200. See e.g., Pandey, V. N., in Neem: Research and Development (eds Randhawa, N. S. and Parmar, B. S.), Society of Pesticide Science, New Delhi, India, 1993.
201. See e.g., Garg, D. S., Agarwal, J. P. and Garg, D. D. (eds), Dhanvaniri, 1967, 41, 133. .
202. Khalid, S. A., Duddeck, H. and Gonzalez- Sierra, M., J. Nat. Prod., 1989, 52, 922.
203. MacKinnon, S. et al., J. Nat. Prod., 1997, 60, 336.
204. In 1988, the world pharmaceutical industry sales were estimated to be worth $ 100 billion a year (C&EN, 1988, Aug. 29, 16).
205. The annual growth rate has been computed as around 11% (see e.g., C&EN, 1996, Nov. 18, 18).
206. Last year's turnover for India's pharmaceutical industry has been estimated at Rs 9000 crores.
207. See e.g., Gamerman, G. E. and Mackler, B. F., Chemtech, 1994, 24, 37.
208. Since a very significant contribution to the overall cost is from the salaries, in developing countries where salaries may be one-fifth of those prevailing in developed countries, the cost of discovering and developing new drugs would be far lower.
209. See e.g., a. Snyder, J., Breuning, R., Derguini, F. and Nakanishi, K., in Natural Products of Woody Plants (ed. Rowe, J. W.), Springer, Berlin, vol. I, 1989, p. 27;
210. b. Mandava, N. B. (ed.), CRC Handbook of Natural Pesticides: Methods, CRC Press, Boca Raton, vol. II, 1985.
211. I am keenly aware that a well-focused, pointed activity on a single biological activity would have led to more concrete results, but such an effort was not feasible, as our work depended heavily on outside help, not only for biological screening, but also for certain chemical facilities. Under the circumstances general screening appeared more appropriate for optimal utilization of the time and manpower. This effort was expected to provide, at least, further concordance (or otherwise) to Ayurvedic claims.
212. Darnell, J., Lodish, H. and Baltimore, D., Molecular Cell Biology, Scientific American Books, New York, 1990, pp. 784-802.
213. Sci. Am.: September 1992 issue is entirely on mind and brain.
214. Skinner, K. J., C&EN, 1991, Oct. 7, 24.
215. Fischbach, G. D., Sci. Am., 1992, 267, 48.
216. Feldman, P. L., Griffith, O. W. and Stuehr, D. J., C&EN, 1993, Dec. 20, 26.
217. Bowery, N., TiPS Rev., 1989, 10, 401.
218. Willetts, J., Balstcr, R. L. and Leander, J. D., TiPS Rev., 1990, 11, 423.
219. Johnson, G., Annu. Rep. Med. Chem., 1989, 24, 41.
220. Johnson, G. and Bigge, C. F., Annu. Rep. Med. Chem., 1991, 26, 11.
221. See e.g., Bloom, F. E., Annu. Rep. Med. Chem., 1969, 4, 270.
222. Winkler, J. et al., Nature, 1995, 375, 484
223. Hershenson, F. M. and Moos, W. H., J. Med. Chem., 1986, 29, 1125.
224. Hershenson, F. M., Marriott, J. G. and Moos, W. H., Annu. Rep. Med. Chem., 1986, 21, 31.
225. Mattson, R. J. and Moon, S. L., Annu. Rep. Med. Chem., 1988, 23, 29.
226. Pavia, M. R., Davis, R. E. and Schwarz, R. D., Annu. Rep. Med. Chem., 1990, 25, 21.
227. Selkoe, D. J., Sci. Am., 1992, 267, 135.
228. See e.g., ref. 196, p. 26.
229. Miranda, R. C. and Sohrabji, F., Annu. Rep. Med. Chem., 1996, 31, 11.
230. Flood, J. F., Morley, J. E. and Roberts, E., Proc. Natl. Acad. Sci USA, 1992, 89, 1567.
231. Brennan, M., C&EN, 1996, Sept. 30. 8.
232. Brennan, M. B., C&EN, 1997, Jan. 20, 29.
233. It has been reasonably assumed that anti-aging also includes arrest of cognition decline. See, e.g., Zs.-Nagy, I., Harman, D. and Kitani, K. (eds), Pharmacology of Aging Processes, The New York Academy of Sciences, New York, 1994.
234. Summary of some results were presented at the New Clinical Drug Evaluation Unit Programme (Boca Raton, Florida, June, 1993)
235. and at Annual Meeting of American Society of Pharmacognosy (San Diego, California, July, 1993).
236. This has several other pharmacological and clinical implications. See e.g., Krogsgaard-Larsen, P. and Christensen, A. V., Annu. Rep. Med. Chem., 1980, 15, 41; Ref. 187;
237. Satish, P. R. and Balasubramanian, A. S., Curr. Sci., 1995, 69, 336.
238. Emson, P. C. and Sandberg, B. E. B., Annu. Rep. Med. Chem., 1983, 18, 31.
239. Jensen, R. T., Wank, S.A., Rowley, W. H., Sato, S. and Gardner, J. D., TiPS, 1989, 10, 418.
240. Nadzan, A. M. and Kerwin, J. F., Annu. Rep. Med. Chem., 1991, 26, 191.
241. See e.g., Willson, T. et al., J. Med. Chem., 1996, 39, 2655, 3030.
242. See e.g., Garg, D. S., Agarwal, J. P. and Garg, D. D. (eds), Dhawanlri, 1971, 38, 430.
243. Misra, R., Cott, J., Silverlon, J., Bhat, B. and Sukh Dev, Proceedings of the International Research Congress on Natural Products, 35th Annual Meeting of the American Society of Pharmacognosy, Halifax, Canada, 1994.
244. Bisset, N. G. (ed. and translator of the German edition), Herbal Drugs and Phytopharmaceuticals, CRC Press, Boca Raton, 1994.
245. Rawls, R., C&EN, 1996, Sept. 23, 53.
246. Martin, C. M., The Consultant Pharmacist, 1997, 12, 631.
247. Tyler, V. E., Chemiech, 1997, 27, 52.
248. Phytomedicine, 1994, 1, 173.
249. Pharma People/Express Pharma Pulse, 1997, July 24, 6.
250. See e.g., The Hindustan Times, 1997, June 29, 21;
251. Express Pharma Pulse, 1997, July 24, 11:
252. Global, 1997, July, 46.
253. Anon, Chemtech, 1996, 26, 17.
254. Chemical Marketing Rep., 1987, Sept. 7, 5.
255. Taylor, N., Plant Drugs that Changed the World, George Allen and Unwin, London, 1965.
256. Lewis, W. H. and Elvin-Lewis, Medical Botany, Wiley-Interscience, New York, 1977.
257. Codd, L. W. et at. (eds), Materials and Technology, Longman, London, vol. V, 1972, p. 707.
258. Atal, C. K., Chemistry and Pharmacology of Vasicine - A New Oxytocic and Abortifacient, Regional Research Laboratory, Jammu, India, 1980.
259. Choudhury, B. R. and Poddar, M. K., IRCS Med. Sci., Libr. Campend., 1984, 12, 466.
260. Choudhury, S. K., Indian J. Exp. Biol., 1978, 16, 830.
261. Singh, K. P., J. Int. Inst. Ayurveda (Coimbatore, India), 1983, 2, 208.
262. Ravikumar, P. R., Soman, R., Chetly, G. L., Pandey, R. C. and Sukh Dev, Indian J. Chem., 1987, 26B, 1012.
263. Joshi, S. and Sukh Dev, Indian J. Chem., 1988, 27B, 12.
264. Singh, H. K., Rastogi, R. P., Srimal, R. C. and Dhawan, B. N., Phylotherapy, 1988, 2, 70.
265. Chandra, S. S. et al., Indian J. Pluirm. Sci., 1978, 40, 97.
266. Boitcau, P. and Batsimamanga, A. R., Therapie (Paris), 1956, 11, 125.
267. Morisset, R. et al., Phytother. Res., 1987/13, 117.
268. Rastogi, R. P. and Dhawan, B. N., Indian J. Med. Res., 1982, 76, 27.
269. Thyagarajan, S. P., Thiruneelakantan, K., Subramanian, S. and Sundravelu, T., Indian J. Med. Res., 1982, 76 (suppl.), 124.
270. Venkateswaran, P. S., Millman, I. and Blumberg, B. S., Proc. Natl. Acad. Sci. USA, 1987, 84, 274.
271. Dixit, S. P. and Achar, M. P., J. Natl. Integ. Med. Assoc., 1983, 25, 269.
272. Thyagarajan, R., Uma, R., Ramanathan, C. P. and Ganapathiraman, K., J. Res. Indian Med. Yoga and Homoepathy, 1977, 12, 1.
273. Singh, B. and Rastogi, R. P., Indian J. Chem., 1972, 10, 29.
274. Pandey, V. N. and Chaturvedi, G. N., J. Res. Indian Med., 1970, 5, 11.
275. Kloss, P. and Schwabe, Ger. Patent, 2 203 884, 1973.
276. Ansari, R. A. et al., Indian J. Med. Res., 1988, 87, 401.
277. Sharma, P. V., Dravyaguna Vignana, Choukhamba Bharti Academy, Varanasi, India, 1986, vol. II.
278. Goyal, H. S., Sukumar and Purushotaman, K. K., J. Res. Ayur. Siddha, 1981, 2, 286.
279. Sharma, K. D., Kapoor, M. L., Vaidya, S. P. and Sharma, L. K., J. Res. Ayur. Siddha, 1981, 2, 309.